Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Initial experiences with subcutaneous recombinant human hyaluronidase.

Rosene D Pirrello¹, Christina Ting Chen, Sandra H Thomas

¹San Diego Hospice & Palliative Care, San Diego, California 92103, USA. rpirrello@sdhospice.org

Journal of Palliative Medicine

|September 7, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022

Same author

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.

Blood advances·2021

Same author

The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma.

Cancer immunology research·2020

Same author

Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.

Science translational medicine·2020

Same author

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017

Same author

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2017

Recombinant human hyaluronidase (rHuPH20) safely enhanced subcutaneous hydration and drug delivery in hospice patients. This enzyme facilitated higher flow rates for fluids and medications, improving symptom management.

Area of Science:

Biochemistry
Pharmacology
Palliative Care

Background:

Subcutaneous hydration and drug infusion are crucial in palliative care.
Limitations exist in achieving adequate flow rates for fluids and medications via subcutaneous routes.
Recombinant human hyaluronidase (rHuPH20) has potential to overcome these limitations.

Purpose of the Study:

To evaluate the safety and efficacy of rHuPH20 in facilitating subcutaneous hydration and drug infusion in a hospice setting.
To assess the impact of rHuPH20 on achieved flow rates and patient symptom management.

Main Methods:

Retrospective observational study of 32 hospice patients over 6 months.
rHuPH20 used to enhance hypodermoclysis for hydration and subcutaneous infusion of medications.

Related Experiment Videos

Flow rates and adverse events were monitored.

Main Results:

rHuPH20 facilitated subcutaneous hydration at rates up to 500 mL/hr.
Electrolyte replacement (potassium, magnesium) was achieved without incident.
Subcutaneous infusion of 9 medications was enhanced, overcoming standard flow rate limitations.
No significant adverse events were reported; mild induration and transiently elevated lidocaine levels were noted.

Conclusions:

rHuPH20 is a safe and effective adjunct for subcutaneous hydration and drug delivery in hospice care.
The enzyme enables higher infusion volumes and rates, improving symptom control and medication administration.
Further investigation into broader inpatient and outpatient applications is warranted.